These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37259219)

  • 41. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer.
    Li J; Chang JY; Jiang ZL; Yin YK; Chen JY; Jin W; Li H; Feng L
    Chin J Integr Med; 2023 Mar; 29(3):233-243. PubMed ID: 36094770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells.
    Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q
    Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies.
    Peng SB; Zhang X; Paul D; Kays LM; Ye M; Vaillancourt P; Dowless M; Stancato LF; Stewart J; Uhlik MT; Long H; Chu S; Obungu VH
    PLoS One; 2016; 11(3):e0150585. PubMed ID: 26954567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Exploration of the therapeutic mechanism of
    Xu M; Zhang P; Zhang G
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):805-814. PubMed ID: 35790430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
    Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
    Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis.
    Wang L; Li W; Lin M; Garcia M; Mulholland D; Lilly M; Martins-Green M
    Carcinogenesis; 2014 Oct; 35(10):2321-30. PubMed ID: 25023990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Yishen Tonglong Decoction inhibits the epithelial-mesenchymal transition and Ras/ERK signaling pathway in human prostate cancer DU-145 cells].
    Liu DG; Li ZR; Chen QH; Zhao J; Su YF; Xiang SZ; Lin MJ
    Zhonghua Nan Ke Xue; 2021 Oct; 27(10):909-916. PubMed ID: 34914270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
    Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X
    Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer].
    Guo Q; Wu XH; Lü YP; Yang B; Xu F; Zhang SJ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(21):1677-80. PubMed ID: 24125682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
    Yin B; Bi YM; Fan GJ; Xia YQ
    J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [
    Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer.
    Wu Z; Zhu Q; Yin Y; Kang D; Cao R; Tian Q; Zhang Y; Lu S; Liu P
    Cancer Med; 2018 Apr; 7(4):1546-1559. PubMed ID: 29533017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway.
    Zhao Z; Ma X; Ma J; Sun X; Li F; Lv J
    Chem Biol Interact; 2018 Apr; 286():45-51. PubMed ID: 29510123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.
    Pratheeshkumar P; Budhraja A; Son YO; Wang X; Zhang Z; Ding S; Wang L; Hitron A; Lee JC; Xu M; Chen G; Luo J; Shi X
    PLoS One; 2012; 7(10):e47516. PubMed ID: 23094058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
    Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Crypotanshione reduces the expression of metadherin in DU145 prostate cancer cells].
    Yao Y; Li HZ; Qian BJ; Liu CM; Zhang JB; Lin MC
    Zhonghua Nan Ke Xue; 2015 Sep; 21(9):782-7. PubMed ID: 26552209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.